US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.05

-0.0260-1.25%

Post-market: 2.120.0659+3.21%19:37 EDT

Volume:96.59K

Turnover:199.80K

Market Cap:34.74M

PE:-0.87

High:2.10

Open:2.09

Low:2.03

Close:2.08

Loading ...

Overview Company News Filings

BRIEF-NRX Pharma Files Initial Section Of U.S. New Drug Application To The FDA For NRX-100

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (Iv Ketamine) for the Treatment of Suicidal Depression

THOMSON REUTERS

NRX Pharmaceuticals Inc - Completion of Nda Filing Expected in Q1 2025

THOMSON REUTERS

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression

New Strong Buy Stocks for December 30th

New Strong Buy Stocks for December 26th

New Strong Buy Stocks for December 24th

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024

NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

BRIEF-NRx Pharmaceuticals Announces Publication Of Paper Entitled "Quality Assurance Of Depression Ratings In Psychiatric Clinical Trials"

NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"

THOMSON REUTERS

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"

NRX Pharmaceuticals Inc (NRXP) Q3 2024 Earnings Call Highlights: Significant Reduction in ...

NRx Pharmaceuticals names Michael Abrams as CFO

NRX Pharmaceuticals Inc - Interim-CFO Richard Narido to Focus on Hope Therapeutics Acquisitions

THOMSON REUTERS

NRX Pharmaceuticals (Nasdaq:Nrxp) Appoints Michael Abrams as Chief Financial Officer

THOMSON REUTERS

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer

NRX Pharmaceuticals Inc reports results for the quarter - Earnings Summary

Press Release: NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update

NRX Pharmaceuticals Files Registration Statement for Sale of Stock by Shareholders

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NRXP/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRXP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRXP\",,,,,undefined,":{"symbol":"NRXP","market":"US","secType":"STK","nameCN":"NRX Pharmaceuticals Inc.","latestPrice":2.054,"timestamp":1746216000000,"preClose":2.08,"halted":0,"volume":96587,"hourTrading":{"tag":"盘后","latestPrice":2.1199,"preClose":2.054,"latestTime":"19:37 EDT","volume":559,"amount":1176.8787,"timestamp":1746229069027},"delay":0,"floatShares":14026009,"shares":16915647,"eps":-2.360476,"marketStatus":"Market Closed","change":-0.026,"latestTime":"05-02 16:00:00 EDT","open":2.09,"high":2.1,"low":2.03,"amount":199802.08970100002,"amplitude":0.033654,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.360476,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.08,"preHourTrading":{"tag":"盘前","latestPrice":2.11,"preClose":2.08,"latestTime":"09:02 EDT","volume":371,"amount":771.113483,"timestamp":1746190960669},"postHourTrading":{"tag":"盘后","latestPrice":2.1199,"preClose":2.054,"latestTime":"19:37 EDT","volume":559,"amount":1176.8787,"timestamp":1746229069027},"volumeRatio":0.8990390350962223,"impliedVol":1.5335,"impliedVolPercentile":0.48},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRXP\",,,,,undefined,":{"symbol":"NRXP","floatShares":14026009,"roa":"-224.60%","roe":"-682.61%","lyrEps":-2.360476,"volumeRatio":0.8990390350962223,"shares":16915647,"dividePrice":0,"high":2.1,"amplitude":0.033654,"preClose":2.08,"low":2.03,"week52Low":1.1,"pbRate":"-1.50","week52High":6.01,"institutionHeld":0,"latestPrice":2.054,"eps":-2.360476,"divideRate":0,"volume":96587,"delay":0,"ttmEps":-2.360476,"open":2.09,"prevYearClose":2.2,"prevWeekClose":2.07,"prevMonthClose":2.12,"prevQuarterClose":2.05,"fiveDayClose":2.07,"twentyDayClose":1.87,"sixtyDayClose":2.84},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRXP\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2495544639","title":"BRIEF-NRX Pharma Files Initial Section Of U.S. New Drug Application To The FDA For NRX-100","url":"https://stock-news.laohu8.com/highlight/detail?id=2495544639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495544639?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:14","pubTimestamp":1735564470,"startTime":"0","endTime":"0","summary":"BRIEF-NRX Pharma Files Initial Section Of U.S. New Drug Application To The FDA For NRX-100 Dec 30 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:NRX PHARMACEUTICALS, INC. (NASDAQ:NRXP) FILES INITIAL SECTI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA8PKGXK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2495541461","title":"NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (Iv Ketamine) for the Treatment of Suicidal Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2495541461","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495541461?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:03","pubTimestamp":1735563782,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA8PKGXK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2495541416","title":"NRX Pharmaceuticals Inc - Completion of Nda Filing Expected in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2495541416","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495541416?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:03","pubTimestamp":1735563782,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA8PKGXK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2495154057","title":"NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2495154057","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495154057?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:03","pubTimestamp":1735563780,"startTime":"0","endTime":"0","summary":"Aiming to be the first FDA-approved medication to treat suicidal depression. Designed to help address the needs of the more than 13 million Americans who seriously consider suicide each year . Completion of NDA filing expected in the first quarter of 2025. Company to participate in 1x1 meetings in San Francisco during the Annual J.P. Morgan Healthcare Conference on January 13-16, 2025, in San Francisco, CA. To schedule meetings, please contact jpm@astrpartners.com. While assembly of the clinical data sections is being completed, FDA has asked the Company to submit the 1800-page manufacturing section  of the NDA to enable immediate review prior to submission of final efficacy data and other sections of the NDA expected in the first quarter of 2025.Intravenous ketamine is widely accepted as a standard of care for acute treatment of suicidal depression, in the absence of an FDA-labeled product; the only treatment currently approved by the FDA is electroconvulsive therapy . According to th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-inc-nasdaq-nrxp-130300981.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-inc-nasdaq-nrxp-130300981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","USAW.SI","IE00BKPKM429.USD","TQQQ","IE00BGHQF748.EUR","QID","LU2210150020.SGD","BK4588","USJW.SI","SQQQ","BK4007","IE00B3QW5Z07.USD","BK4585","NQmain","LU2095319765.USD","CDC","NRXP","NDAQ","NVIW.SI","BK4112","MNQmain",".IXIC","QLD","LU2210149790.SGD","NRXPW","TSYW.SI","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2495311544","title":"New Strong Buy Stocks for December 30th","url":"https://stock-news.laohu8.com/highlight/detail?id=2495311544","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495311544?lang=en_us&edition=fundamental","pubTime":"2024-12-30 19:18","pubTimestamp":1735557480,"startTime":"0","endTime":"0","summary":"Here are five stocks added to the Zacks Rank #1  List today:. CoreCard Corporation CCRD: This technology solutions and processing services company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.Appian Corporation APPN: This software company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.USANA Health Sciences, Inc. USNA: This nutritional, personal care, and skincare products company has seen the Zacks Consensus Estimate for its next year earnings increasing 12.8% over the last 60 days.Entrada Therapeutics, Inc. TRDA: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.Entrada Therapeutics, Inc. price-consensus-chart | Entrada Therapeutics, Inc. Quote. NRx Pharmaceuticals, Inc. NRXP: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-buy-stocks-december-30th-111800365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["APPN","BK4097","BK4007","BK4023","TRDA","NRXP","BK4183","CCRD","BK4532","BK4139","BK4548","USNA"],"gpt_icon":0},{"id":"2494510838","title":"New Strong Buy Stocks for December 26th","url":"https://stock-news.laohu8.com/highlight/detail?id=2494510838","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494510838?lang=en_us&edition=fundamental","pubTime":"2024-12-26 17:58","pubTimestamp":1735207080,"startTime":"0","endTime":"0","summary":"Here are five stocks added to the Zacks Rank #1  List today:. eGain CorporationEGAN: This customer engagement solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 27.8% over the last 60 days.ACM Research, Inc.ACMR: This semiconductor cleaning equipment provider has seen the Zacks Consensus Estimate for its current year earnings increasing 18.4% over the last 60 days.ACM Research, Inc. price-consensus-chart | ACM Research, Inc. Quote. Mission Produce, Inc.AVO: This agribusiness company has seen the Zacks Consensus Estimate for its current year earnings increasing 44.8% over the last 60 days.BlackBerry LimitedBB: This intelligent security software and services provider has seen the Zacks Consensus Estimate for its current year earnings increasing 150% over the last 60 days.NRx Pharmaceuticals, Inc.NRXP: This bio-pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.You","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-buy-stocks-december-26th-095800462.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4547","BK4007","ACMR","NRXP","BK4212","EGAN","BK4575","BK4097","AVO","BB","BK4023","BK4147","BK4505"],"gpt_icon":1},{"id":"2493083553","title":"New Strong Buy Stocks for December 24th","url":"https://stock-news.laohu8.com/highlight/detail?id=2493083553","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493083553?lang=en_us&edition=fundamental","pubTime":"2024-12-24 18:50","pubTimestamp":1735037400,"startTime":"0","endTime":"0","summary":"Here are five stocks added to the Zacks Rank #1  List today:. TechnipFMC plcFTI: This energy solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.6% over the last 60 days.NRx Pharmaceuticals, Inc.NRXP: This bio-pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote. Powell Industries, Inc.POWL: This custom equipment manufacturer the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.Vimeo, Inc.VMEO: This video software solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 125% over the last 60 days.Puma Biotechnology, Inc. PBYI: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 14% over the last 60 days.You can seethe complete list of today’s","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fcVDrlmKLuRIlyCr4UandQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0afd90d16431e68632d244c19d16e541","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fcVDrlmKLuRIlyCr4UandQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0afd90d16431e68632d244c19d16e541"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-buy-stocks-december-24th-105000599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["US2Y.BOND","NRXP","LU0300736062.USD","US7Y.BOND","US10Y.BOND","US3Y.BOND","BK4096","BK4007","US12M.BOND","BK4179","BK4585","BK4588","BK4139","BK4077","PBYI","LU0300736492.USD","US5Y.BOND","US30Y.BOND","FTI","US6M.BOND","LU0054578231.USD","LU0053671581.USD","VMEO"],"gpt_icon":0},{"id":"2486077461","title":"NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2486077461","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486077461?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:03","pubTimestamp":1732626180,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., Nov. 26, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company, today announced that Dr. Jonathan Javitt, Chairman, CEO and Chief Scientistwill present at NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL.- on Tuesday December 3, 2024 at 1:00PM Eastern Standard Time.NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7HRDUBVwDDdTEOMS.ImfaQ--~B/aD0zMzc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7HRDUBVwDDdTEOMS.ImfaQ--~B/aD0zMzc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-130300362.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-130300362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2210150020.SGD","NRXPW","QID","IE00B3QW5Z07.USD","SQQQ","BK4585","IE00BGHQF748.EUR","BK4588","BK4007","LU2095319765.USD","EQR","IE00B64PRP62.GBP","QLD","NDAQ","BK4215","IE00BKPKM429.USD","MNQmain","NBL","BK4112","NRXP","TQQQ","NQmain","LU2210149790.SGD",".IXIC","PSQ"],"gpt_icon":1},{"id":"2486841250","title":"NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2486841250","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486841250?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:48","pubTimestamp":1732542480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRXP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2024 08:48 ET (13:48 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP"],"gpt_icon":0},{"id":"2486089006","title":"BRIEF-NRx Pharmaceuticals Announces Publication Of Paper Entitled \"Quality Assurance Of Depression Ratings In Psychiatric Clinical Trials\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2486089006","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486089006?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:22","pubTimestamp":1732540933,"startTime":"0","endTime":"0","summary":"BRIEF-NRx Pharmaceuticals Announces Publication Of Paper Entitled \"Quality Assurance Of Depression Ratings In Psychiatric Clinical Trials\"Nov 25 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:NRX PHARMACE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nTUA5FRZXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP"],"gpt_icon":0},{"id":"2486860230","title":"NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Publication of Paper Entitled \"Quality Assurance of Depression Ratings in Psychiatric Clinical Trials\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2486860230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486860230?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:03","pubTimestamp":1732539783,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nTUA5FRZXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2486089354","title":"NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled \"Quality Assurance of Depression Ratings in Psychiatric Clinical Trials\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2486089354","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486089354?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:03","pubTimestamp":1732539780,"startTime":"0","endTime":"0","summary":"NRx-developed training and monitoring methodology in recently completed phase 2b/3 clinical trial of NRX-101 documents higher interrater reliability  on primary endpoint  than previously reported industry standards. Positive implications for conduct of future registration trials for NRX-101 and similar medications.Published in the peer reviewed American Journal of Clinical Psychopharmacology. \"The rater training and monitoring methodology achieved by NRx's research team enabled the team to identify statistically significant improvements in recovery from suicidality and reduction in akathisia  with a compact study design of 90 patients. This methodology enabled statistical significance to be achieved with fewer than 100 participants, where typically several hundred would have been required,\" said Dr. Jonathan Javitt, Chairman, CEO and Chief Scientist of NRx Pharmaceuticals and senior author of the study. \"Clinical trials in antidepressant drugs rely on close coordination of human psycho","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7HRDUBVwDDdTEOMS.ImfaQ--~B/aD0zMzc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7HRDUBVwDDdTEOMS.ImfaQ--~B/aD0zMzc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-130300810.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-130300810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NRXP","NDAQ","NRXPW",".IXIC"],"gpt_icon":0},{"id":"2484596704","title":"NRX Pharmaceuticals Inc (NRXP) Q3 2024 Earnings Call Highlights: Significant Reduction in ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2484596704","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484596704?lang=en_us&edition=fundamental","pubTime":"2024-11-19 15:03","pubTimestamp":1731999785,"startTime":"0","endTime":"0","summary":"Net Operating Loss Reduction: 74% reduction in net operating losses compared to Q3 2023.Net Loss: Reduced to $1.6 million in Q3 2024 from $6.1 million in Q3 2023.Research and Development Expenses: Decreased from $3.3 million in Q3 2023 to $0.6 million in Q3 2024.General and Administrative Expenses: Slight decrease from $2.5 million in Q3 2023 to $2.4 million in Q3 2024.Cash and Cash Equivalents: $1.6 million as of September 30, 2024.Additional Financing: Secured $5.4 million in tranche two of secured debt financing post-September 30, 2024.Net Loss for Nine Months: Reduced to $16.1 million in 2024 from $25.8 million in 2023.Research and Development Expenses for Nine Months: $5.2 million in 2024, down from $10.8 million in 2023.General and Administrative Expenses for Nine Months: Decreased to $10.9 million in 2024 from $12.3 million in 2023.GuruFocus has detected 2 Warning Signs with NRXP.The company is advancing its life-saving products, NRX-100 and NRX-101, for new drug application fil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-inc-nrxp-q3-070305527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NRXPW","NRXP"],"gpt_icon":0},{"id":"2484989007","title":"NRx Pharmaceuticals names Michael Abrams as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2484989007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484989007?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:10","pubTimestamp":1731964251,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals (NRXP) announced it has appointed Michael Abrams as its permanent CFO. Abrams succeeds Interim-CFO Richard Narido, who will con...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-names-michael-abrams-as-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-names-michael-abrams-as-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2484989379","title":"NRX Pharmaceuticals Inc - Interim-CFO Richard Narido to Focus on Hope Therapeutics Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2484989379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484989379?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:05","pubTimestamp":1731963904,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUA8KKN2N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2484598930","title":"NRX Pharmaceuticals (Nasdaq:Nrxp) Appoints Michael Abrams as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2484598930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484598930?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:05","pubTimestamp":1731963904,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUA8KKN2N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2210149790.SGD","BK4007","BK4585","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2095319765.USD","NDAQ","NRXP","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4588"],"gpt_icon":0},{"id":"2484998954","title":"NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2484998954","media":"PR Newswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484998954?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:05","pubTimestamp":1731963900,"startTime":"0","endTime":"0","summary":"Industry veteran with extensive experience in key areas of focus. Interim-CFO Richard Narido to focus on HOPE Therapeutics acquisition opportunities. WILMINGTON,Del., Nov. 18, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company, today announced it has appointed Michael Abrams as its permanent Chief Financial Officer. Mr. Abrams succeedsInterim-CFO Richard Narido, who will continue to support the Company's financial function and other projects.\"We are delighted to welcome Mike to the NRx team. Mike's combination of public companyCFO experience in the biotechnology sector, together with investment banking expertise is ideally suited to NRx's needs as we aim to become a revenue generating, profitable biotechnology company,\" said Dr. JonathanJavitt, Chairman, CEO and Chief Scientist of NRx Pharmaceuticals. \"Additionally, we thank Rich for his outstanding service to the Company as ourInterim-CFO and look forward to his ongoing contributions as HOPE T","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7HRDUBVwDDdTEOMS.ImfaQ--~B/aD0zMzc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7HRDUBVwDDdTEOMS.ImfaQ--~B/aD0zMzc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5df666b7a53f66e1d5843817ccb10779"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-appoints-210500504.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-appoints-210500504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B3QW5Z07.USD","NDAQ","TQQQ","MNQmain","NRXP","NQmain","BK4585","BK4112","BK4007","QID",".IXIC","LU2210149790.SGD","QLD","BK4588","PSQ","NRXPW","LU2095319765.USD","LU2210150020.SGD","SQQQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2483996371","title":"NRX Pharmaceuticals Inc reports results for the quarter  - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483996371","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483996371?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:09","pubTimestamp":1731679773,"startTime":"0","endTime":"0","summary":"* NRX Pharmaceuticals Inc    reported a quarterly adjusted loss of 13 cents per share for the quarter , higher than the same quarter last year, when the company reported EPS of -70 cents.  The mean ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"NRX Pharmaceuticals Inc reports results for the quarter  - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP"],"gpt_icon":0},{"id":"2483374243","title":"Press Release: NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483374243","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483374243?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:05","pubTimestamp":1731618300,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals  Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update. -- On track to file New Drug Applications  for NRX-100 . in treating suicidal ideation in depression, including bipolar depression. bipolar depression with suicidality or akathisia by year end 2024 with. -- HOPE Therapeutics acquiring Interventional Psychiatry Clinics; key to. developing a best-in-class network of care to prevent suicide, continues. -- 74% reduction in net operating losses compared to 3rd quarter 2023 with. profitability forecast in 2025 from HOPE Therapeutics and from sales of. WILMINGTON, Del., Nov. 14, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company, today announced its financial results for the quarter and year to date ended September 30, 2024 and provided a business update.clinical trials in more than 500 patients in collaboration with leading. US and French Universities that demonstrate a highly significant.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSI","BK4588","NRXP","R","MNQmain","LU2210149790.SGD","BK4112","NDAQ","IE00B3QW5Z07.USD","QLD","LU2095319765.USD","BK4585","IE00BGHQF748.EUR","NPL.SI",".IXIC","IE00B64PRP62.GBP","PSQ","TQQQ","IE00BKPKM429.USD","BK4022","LU2210150020.SGD","BK6100","BK4007","QID","BK4232","NQmain","SQQQ"],"gpt_icon":1},{"id":"2483382093","title":"NRX Pharmaceuticals Files Registration Statement for Sale of Stock by Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2483382093","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483382093?lang=en_us&edition=fundamental","pubTime":"2024-11-15 01:46","pubTimestamp":1731606381,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals  on Thursday filed a preliminary prospectus for the sale of up to  3,304,374 of the company's common stock from time to time by some of its shareholders.The shares are issuable if the holders of the company's 6% senior secured note convert the debt into equity and exercise their warrants for stock in full.The company identified the selling shareholders as Anson Investments Master Fund and Anson East Master Fund.The company said it would not receive any proceeds from the resale of its shares.Shares of NRX Pharmaceuticals were down 6.4% in recent trading.Price: 1.17, Change: -0.08, Percent Change: -6.40","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NRXP","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":108,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRXP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-17","symbol":"NRXP","fiscalQuarterEnding":"2024/12","expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"NRXP","fiscalQuarterEnding":"2024/09","expectedEps":-0.81,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2024-08-14","symbol":"NRXP","fiscalQuarterEnding":"2024/06","expectedEps":-0.81,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2024-05-14","symbol":"NRXP","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2024-04-02","symbol":"NRXP","defaultRemindTime":1712064600000,"type":"split","dateTimestamp":1712030400000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRXP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRXP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NRXP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NRXP","date":"2025-05-02","current":-1.400324,"percent":0.34751,"low":-15.683226,"twenty":-1.850454,"median":-1.118612,"eighty":-0.665406,"high":-0.417835,"avg":-2.083401,"sd":2.672619,"marketCap":35184545},"quantilePoints":[{"date":"2021-05-28","current":-13.797239,"twenty":-14.786877,"median":-13.816053,"eighty":-13.797239,"marketCap":1044119076},{"date":"2021-06-04","current":-12.3548,"twenty":-14.162238,"median":-13.797239,"eighty":-13.370779,"marketCap":934961172},{"date":"2021-06-11","current":-11.821725,"twenty":-13.804765,"median":-13.348828,"eighty":-11.618529,"marketCap":894620208},{"date":"2021-06-18","current":-9.319408,"twenty":-13.797239,"median":-11.821725,"eighty":-10.975076,"marketCap":705254975},{"date":"2021-06-25","current":-8.811418,"twenty":-13.714455,"median":-11.329415,"eighty":-9.118721,"marketCap":666812409},{"date":"2021-07-02","current":-7.488138,"twenty":-13.538854,"median":-10.987619,"eighty":-8.359872,"marketCap":566671898},{"date":"2021-07-09","current":-7.218465,"twenty":-13.370779,"median":-10.73676,"eighty":-7.488138,"marketCap":546264116},{"date":"2021-07-16","current":-5.394473,"twenty":-12.885367,"median":-9.068549,"eighty":-7.019032,"marketCap":408231804},{"date":"2021-07-23","current":-15.683226,"twenty":-12.885367,"median":-8.81769,"eighty":-6.868665,"marketCap":1186842932},{"date":"2021-07-30","current":-9.611279,"twenty":-12.14634,"median":-9.601781,"eighty":-7.019032,"marketCap":727342580},{"date":"2021-08-06","current":-8.699537,"twenty":-11.828879,"median":-9.592284,"eighty":-7.246059,"marketCap":658345655},{"date":"2021-08-13","current":-9.636605,"twenty":-11.806673,"median":-9.696755,"eighty":-7.365217,"marketCap":729259161},{"date":"2021-08-20","current":-7.627107,"twenty":-11.618529,"median":-9.592284,"eighty":-7.484375,"marketCap":578868697},{"date":"2021-08-27","current":-9.468613,"twenty":-11.355491,"median":-9.394011,"eighty":-7.488138,"marketCap":718632012},{"date":"2021-09-03","current":-10.563942,"twenty":-11.323327,"median":-9.611279,"eighty":-7.520672,"marketCap":801763391},{"date":"2021-09-10","current":-8.537592,"twenty":-11.304235,"median":-9.468613,"eighty":-7.580999,"marketCap":647971084},{"date":"2021-09-17","current":-7.581099,"twenty":-11.27109,"median":-9.232189,"eighty":-7.571797,"marketCap":575376813},{"date":"2021-09-24","current":-6.674201,"twenty":-11.177687,"median":-8.968129,"eighty":-7.44789,"marketCap":506546690},{"date":"2021-10-01","current":-6.185326,"twenty":-11.065556,"median":-8.920108,"eighty":-7.191158,"marketCap":469442951},{"date":"2021-10-08","current":-4.924172,"twenty":-10.981348,"median":-8.824646,"eighty":-6.927306,"marketCap":373726061},{"date":"2021-10-15","current":-7.269353,"twenty":-10.929264,"median":-8.809296,"eighty":-6.862862,"marketCap":551716458},{"date":"2021-10-22","current":-7.014288,"twenty":-10.80437,"median":-8.717346,"eighty":-6.911718,"marketCap":532357986},{"date":"2021-10-29","current":-7.177246,"twenty":-10.713083,"median":-8.487996,"eighty":-6.911718,"marketCap":544725899},{"date":"2021-11-05","current":-4.711617,"twenty":-10.607487,"median":-8.341058,"eighty":-6.746469,"marketCap":357594001},{"date":"2021-11-12","current":-4.406956,"twenty":-10.53423,"median":-8.025421,"eighty":-6.657196,"marketCap":334471381},{"date":"2021-11-19","current":-2.799102,"twenty":-10.390058,"median":-7.838447,"eighty":-6.539312,"marketCap":301697033},{"date":"2021-11-26","current":-3.683029,"twenty":-10.288753,"median":-7.772397,"eighty":-6.344204,"marketCap":396969781},{"date":"2021-12-03","current":-3.000986,"twenty":-10.257096,"median":-7.604103,"eighty":-6.1774,"marketCap":323456859},{"date":"2021-12-10","current":-3.213783,"twenty":-10.143128,"median":-7.538588,"eighty":-5.519323,"marketCap":346392890},{"date":"2021-12-17","current":-3.050093,"twenty":-10.130465,"median":-7.485002,"eighty":-4.761213,"marketCap":328749789},{"date":"2021-12-23","current":-2.749995,"twenty":-10.02916,"median":-7.414598,"eighty":-4.500182,"marketCap":296404103},{"date":"2021-12-31","current":-2.60813,"twenty":-9.948991,"median":-7.297693,"eighty":-3.67539,"marketCap":281113415},{"date":"2022-01-07","current":-2.54811,"twenty":-9.92987,"median":-7.243909,"eighty":-3.356194,"marketCap":274644278},{"date":"2022-01-14","current":-2.378964,"twenty":-9.90281,"median":-7.184331,"eighty":-3.235609,"marketCap":256413073},{"date":"2022-01-21","current":-1.806048,"twenty":-9.812696,"median":-7.12765,"eighty":-3.105748,"marketCap":194662218},{"date":"2022-01-28","current":-1.702378,"twenty":-9.684725,"median":-7.070968,"eighty":-2.990074,"marketCap":183488254},{"date":"2022-02-04","current":-1.811416,"twenty":-9.621409,"median":-7.014288,"eighty":-2.843844,"marketCap":195240740},{"date":"2022-02-11","current":-1.58267,"twenty":-9.599882,"median":-6.847109,"eighty":-2.741265,"marketCap":170585766},{"date":"2022-02-18","current":-1.755775,"twenty":-9.518081,"median":-6.709627,"eighty":-2.7118,"marketCap":189243584},{"date":"2022-02-25","current":-1.817598,"twenty":-9.408931,"median":-6.674201,"eighty":-2.623408,"marketCap":195907091},{"date":"2022-03-04","current":-1.564123,"twenty":-9.30446,"median":-6.596265,"eighty":-2.55684,"marketCap":168586714},{"date":"2022-03-11","current":-1.792869,"twenty":-9.242159,"median":-6.53415,"eighty":-2.455352,"marketCap":193241688},{"date":"2022-03-18","current":-1.947426,"twenty":-9.159657,"median":-6.372696,"eighty":-2.097111,"marketCap":209900454},{"date":"2022-03-25","current":-1.712499,"twenty":-9.062631,"median":-6.256178,"eighty":-1.978124,"marketCap":184579130},{"date":"2022-04-01","current":-1.732933,"twenty":-8.963124,"median":-6.143669,"eighty":-1.909163,"marketCap":161271979},{"date":"2022-04-08","current":-1.54675,"twenty":-8.944214,"median":-5.994028,"eighty":-1.853455,"marketCap":143945238},{"date":"2022-04-14","current":-1.732933,"twenty":-8.924309,"median":-5.394473,"eighty":-1.818834,"marketCap":161271979},{"date":"2022-04-22","current":-1.21735,"twenty":-8.903186,"median":-4.782469,"eighty":-1.807122,"marketCap":113290233},{"date":"2022-04-29","current":-1.117098,"twenty":-8.855736,"median":-4.562829,"eighty":-1.762045,"marketCap":103960449},{"date":"2022-05-06","current":-1.081293,"twenty":-8.823255,"median":-4.413295,"eighty":-1.750557,"marketCap":100628384},{"date":"2022-05-13","current":-0.945236,"twenty":-8.816436,"median":-3.683029,"eighty":-1.73441,"marketCap":87966534},{"date":"2022-05-20","current":-1.233763,"twenty":-8.810569,"median":-3.508425,"eighty":-1.729936,"marketCap":99961971},{"date":"2022-05-27","current":-0.439713,"twenty":-8.792021,"median":-3.24925,"eighty":-1.712499,"marketCap":35626446},{"date":"2022-06-03","current":-0.604133,"twenty":-8.731414,"median":-3.241065,"eighty":-1.702378,"marketCap":48948045},{"date":"2022-06-10","current":-0.47286,"twenty":-8.717346,"median":-3.183774,"eighty":-1.664183,"marketCap":38312091},{"date":"2022-06-17","current":-0.44654,"twenty":-8.699537,"median":-3.050093,"eighty":-1.620533,"marketCap":36179569},{"date":"2022-06-24","current":-0.505843,"twenty":-8.569981,"median":-3.009171,"eighty":-1.599865,"marketCap":40984408},{"date":"2022-07-01","current":-0.46225,"twenty":-8.458238,"median":-2.973705,"eighty":-1.563513,"marketCap":37452418},{"date":"2022-07-08","current":-0.477055,"twenty":-8.398809,"median":-2.900044,"eighty":-1.54628,"marketCap":38651962},{"date":"2022-07-15","current":-0.450735,"twenty":-8.353601,"median":-2.799102,"eighty":-1.31617,"marketCap":36519440},{"date":"2022-07-22","current":-0.440865,"twenty":-8.259178,"median":-2.739082,"eighty":-1.217335,"marketCap":35719744},{"date":"2022-07-29","current":-0.65225,"twenty":-8.120904,"median":-2.717257,"eighty":-1.197299,"marketCap":52846562},{"date":"2022-08-05","current":-0.637527,"twenty":-8.017483,"median":-2.709072,"eighty":-1.128482,"marketCap":51653682},{"date":"2022-08-12","current":-0.65776,"twenty":-7.908743,"median":-2.60813,"eighty":-1.109937,"marketCap":53293058},{"date":"2022-08-19","current":-0.548368,"twenty":-7.846036,"median":-2.572663,"eighty":-0.958126,"marketCap":48194436},{"date":"2022-08-26","current":-0.537978,"twenty":-7.803069,"median":-2.482634,"eighty":-0.780241,"marketCap":47281278},{"date":"2022-09-02","current":-0.519661,"twenty":-7.775231,"median":-2.455352,"eighty":-0.661676,"marketCap":45671415},{"date":"2022-09-09","current":-0.538825,"twenty":-7.758227,"median":-2.387148,"eighty":-0.643416,"marketCap":47355683},{"date":"2022-09-16","current":-0.561837,"twenty":-7.693026,"median":-2.040161,"eighty":-0.607444,"marketCap":49378159},{"date":"2022-09-23","current":-0.519815,"twenty":-7.608704,"median":-1.996885,"eighty":-0.590555,"marketCap":45684943},{"date":"2022-09-30","current":-0.569533,"twenty":-7.576448,"median":-1.953609,"eighty":-0.572427,"marketCap":50054572},{"date":"2022-10-07","current":-0.600319,"twenty":-7.557118,"median":-1.910388,"eighty":-0.577449,"marketCap":52760224},{"date":"2022-10-14","current":-0.579,"twenty":-7.518408,"median":-1.879421,"eighty":-0.57859,"marketCap":50886560},{"date":"2022-10-21","current":-0.57723,"twenty":-7.488138,"median":-1.848509,"eighty":-0.577726,"marketCap":50730985},{"date":"2022-10-28","current":-0.623408,"twenty":-7.485629,"median":-1.817598,"eighty":-0.57859,"marketCap":54789464},{"date":"2022-11-04","current":-0.638801,"twenty":-7.464878,"median":-1.811416,"eighty":-0.578861,"marketCap":56142290},{"date":"2022-11-11","current":-0.76964,"twenty":-7.419558,"median":-1.792869,"eighty":-0.579893,"marketCap":67641314},{"date":"2022-11-18","current":-1.286901,"twenty":-7.355791,"median":-1.762177,"eighty":-0.582525,"marketCap":77111097},{"date":"2022-11-25","current":-1.298189,"twenty":-7.303361,"median":-1.758866,"eighty":-0.584556,"marketCap":77787511},{"date":"2022-12-02","current":-1.557827,"twenty":-7.295645,"median":-1.749592,"eighty":-0.584926,"marketCap":93345013},{"date":"2022-12-09","current":-1.512673,"twenty":-7.283831,"median":-1.741864,"eighty":-0.585573,"marketCap":90639360},{"date":"2022-12-16","current":-1.298189,"twenty":-7.259175,"median":-1.732933,"eighty":-0.588236,"marketCap":77787511},{"date":"2022-12-23","current":-1.219169,"twenty":-7.215889,"median":-1.730352,"eighty":-0.589174,"marketCap":73052619},{"date":"2022-12-30","current":-1.253035,"twenty":-7.205586,"median":-1.712894,"eighty":-0.591699,"marketCap":75081858},{"date":"2023-01-06","current":-1.309478,"twenty":-7.188582,"median":-1.712499,"eighty":-0.592377,"marketCap":78463924},{"date":"2023-01-13","current":-1.581563,"twenty":-7.178663,"median":-1.70429,"eighty":-0.592546,"marketCap":94767279},{"date":"2023-01-20","current":-1.468595,"twenty":-7.147488,"median":-1.700134,"eighty":-0.593516,"marketCap":87998188},{"date":"2023-01-27","current":-1.389516,"twenty":-7.114896,"median":-1.669967,"eighty":-0.597479,"marketCap":83259824},{"date":"2023-02-03","current":-1.41211,"twenty":-7.097892,"median":-1.66304,"eighty":-0.599929,"marketCap":84613642},{"date":"2023-02-10","current":-1.265251,"twenty":-7.066717,"median":-1.641632,"eighty":-0.600227,"marketCap":75813823},{"date":"2023-02-17","current":-1.253954,"twenty":-7.032709,"median":-1.625559,"eighty":-0.600319,"marketCap":75136914},{"date":"2023-02-24","current":-1.129688,"twenty":-7.018539,"median":-1.619764,"eighty":-0.601181,"marketCap":67690914},{"date":"2023-03-03","current":-0.903751,"twenty":-6.963003,"median":-1.603573,"eighty":-0.603138,"marketCap":54152731},{"date":"2023-03-10","current":-0.799128,"twenty":-6.874469,"median":-1.581563,"eighty":-0.604177,"marketCap":47883724},{"date":"2023-03-17","current":-0.847418,"twenty":-6.849098,"median":-1.575394,"eighty":-0.605351,"marketCap":50777258},{"date":"2023-03-24","current":-0.87166,"twenty":-6.791814,"median":-1.561072,"eighty":-0.607382,"marketCap":52229877},{"date":"2023-03-31","current":-0.787109,"twenty":-6.718129,"median":-1.557827,"eighty":-0.607969,"marketCap":47163600},{"date":"2023-04-06","current":-0.647641,"twenty":-6.709627,"median":-1.54675,"eighty":-0.608015,"marketCap":38806669},{"date":"2023-04-14","current":-1.118159,"twenty":-6.688371,"median":-1.532429,"eighty":-0.608092,"marketCap":44451275},{"date":"2023-04-21","current":-1.06509,"twenty":-6.674201,"median":-1.512673,"eighty":-0.608657,"marketCap":42341603},{"date":"2023-04-28","current":-1.012022,"twenty":-6.652945,"median":-1.462947,"eighty":-0.610324,"marketCap":40231932},{"date":"2023-05-05","current":-1.065002,"twenty":-6.624605,"median":-1.446001,"eighty":-0.615712,"marketCap":42338075},{"date":"2023-05-12","current":-1.087986,"twenty":-6.567924,"median":-1.417759,"eighty":-0.623408,"marketCap":43251796},{"date":"2023-05-19","current":-1.284565,"twenty":-6.55996,"median":-1.41211,"eighty":-0.623408,"marketCap":47972098},{"date":"2023-05-26","current":-1.279653,"twenty":-6.53415,"median":-1.41211,"eighty":-0.637527,"marketCap":47788648},{"date":"2023-06-02","current":-1.354828,"twenty":-6.521492,"median":-1.405431,"eighty":-0.638546,"marketCap":50596048},{"date":"2023-06-09","current":-1.118552,"twenty":-6.424616,"median":-1.389516,"eighty":-0.645873,"marketCap":41772340},{"date":"2023-06-16","current":-1.120879,"twenty":-6.355601,"median":-1.377715,"eighty":-0.651328,"marketCap":41859218},{"date":"2023-06-23","current":-1.09973,"twenty":-6.329648,"median":-1.363125,"eighty":-0.655556,"marketCap":41069421},{"date":"2023-06-30","current":-1.036284,"twenty":-6.294438,"median":-1.34393,"eighty":-0.657826,"marketCap":38700031},{"date":"2023-07-07","current":-0.994198,"twenty":-6.242008,"median":-1.328409,"eighty":-0.657933,"marketCap":37128336},{"date":"2023-07-14","current":-0.843831,"twenty":-6.183741,"median":-1.309478,"eighty":-0.659207,"marketCap":31512883},{"date":"2023-07-21","current":-0.857842,"twenty":-6.163907,"median":-1.301215,"eighty":-0.665273,"marketCap":32036123},{"date":"2023-07-28","current":-0.743164,"twenty":-6.093475,"median":-1.29915,"eighty":-0.669799,"marketCap":27753451},{"date":"2023-08-04","current":-0.790748,"twenty":-6.020907,"median":-1.296195,"eighty":-0.671167,"marketCap":29530493},{"date":"2023-08-11","current":-0.655608,"twenty":-5.899087,"median":-1.286901,"eighty":-0.665273,"marketCap":24483693},{"date":"2023-08-18","current":-0.691781,"twenty":-5.494353,"median":-1.284565,"eighty":-0.669799,"marketCap":27034807},{"date":"2023-08-25","current":-0.702106,"twenty":-5.300413,"median":-1.276548,"eighty":-0.661044,"marketCap":27438312},{"date":"2023-09-01","current":-0.609387,"twenty":-4.900082,"median":-1.265556,"eighty":-0.657933,"marketCap":23814840},{"date":"2023-09-08","current":-0.505723,"twenty":-4.803724,"median":-1.254806,"eighty":-0.655608,"marketCap":19763654},{"date":"2023-09-15","current":-0.53422,"twenty":-4.761213,"median":-1.253035,"eighty":-0.647641,"marketCap":20877327},{"date":"2023-09-22","current":-0.536698,"twenty":-4.711617,"median":-1.241746,"eighty":-0.623408,"marketCap":20974168},{"date":"2023-09-29","current":-0.552599,"twenty":-4.592587,"median":-1.241746,"eighty":-0.614549,"marketCap":21595565},{"date":"2023-10-06","current":-0.56788,"twenty":-4.528821,"median":-1.233763,"eighty":-0.608544,"marketCap":22192752},{"date":"2023-10-13","current":-0.625701,"twenty":-4.439771,"median":-1.23136,"eighty":-0.607753,"marketCap":24452378},{"date":"2023-10-20","current":-0.588737,"twenty":-4.409492,"median":-1.230458,"eighty":-0.603801,"marketCap":23007831},{"date":"2023-10-27","current":-0.578205,"twenty":-4.384284,"median":-1.230458,"eighty":-0.602806,"marketCap":22596257},{"date":"2023-11-03","current":-0.636645,"twenty":-4.171481,"median":-1.220195,"eighty":-0.604155,"marketCap":24880093},{"date":"2023-11-10","current":-0.650274,"twenty":-3.67539,"median":-1.219169,"eighty":-0.604798,"marketCap":25412719},{"date":"2023-11-17","current":-0.67745,"twenty":-3.619735,"median":-1.213968,"eighty":-0.607197,"marketCap":24428167},{"date":"2023-11-24","current":-0.73536,"twenty":-3.519338,"median":-1.209477,"eighty":-0.607938,"marketCap":26516354},{"date":"2023-12-01","current":-0.806131,"twenty":-3.497513,"median":-1.207881,"eighty":-0.608015,"marketCap":29068279},{"date":"2023-12-08","current":-0.773089,"twenty":-3.38293,"median":-1.195867,"eighty":-0.608092,"marketCap":27876817},{"date":"2023-12-15","current":-0.790196,"twenty":-3.24925,"median":-1.174876,"eighty":-0.608657,"marketCap":28493673},{"date":"2023-12-22","current":-1.008835,"twenty":-3.241065,"median":-1.15601,"eighty":-0.609387,"marketCap":36377599},{"date":"2023-12-29","current":-1.08734,"twenty":-3.241065,"median":-1.144988,"eighty":-0.609949,"marketCap":39208376},{"date":"2024-01-05","current":-1.073279,"twenty":-3.241065,"median":-1.144796,"eighty":-0.610508,"marketCap":38701371},{"date":"2024-01-12","current":-0.972513,"twenty":-3.235609,"median":-1.136551,"eighty":-0.611699,"marketCap":35067836},{"date":"2024-01-19","current":-1.002977,"twenty":-3.213783,"median":-1.135062,"eighty":-0.613517,"marketCap":36166347},{"date":"2024-01-26","current":-0.979777,"twenty":-3.153764,"median":-1.13251,"eighty":-0.615375,"marketCap":35329789},{"date":"2024-02-02","current":-0.876199,"twenty":-3.142851,"median":-1.127033,"eighty":-0.615712,"marketCap":31594853},{"date":"2024-02-09","current":-1.08734,"twenty":-3.050093,"median":-1.118612,"eighty":-0.619299,"marketCap":39208376},{"date":"2024-02-16","current":-1.134208,"twenty":-3.011899,"median":-1.124834,"eighty":-0.622603,"marketCap":40898393},{"date":"2024-02-23","current":-1.031098,"twenty":-3.009717,"median":-1.118612,"eighty":-0.623247,"marketCap":37180357},{"date":"2024-03-01","current":-0.906076,"twenty":-3.002623,"median":-1.118355,"eighty":-0.623408,"marketCap":32672199},{"date":"2024-03-08","current":-1.67695,"twenty":-2.979161,"median":-1.118612,"eighty":-0.625242,"marketCap":60469123},{"date":"2024-03-15","current":-1.084037,"twenty":-2.973705,"median":-1.118612,"eighty":-0.629831,"marketCap":39089296},{"date":"2024-03-22","current":-1.285322,"twenty":-2.956244,"median":-1.124834,"eighty":-0.630863,"marketCap":46347426},{"date":"2024-03-28","current":-1.348685,"twenty":-2.889677,"median":-1.129688,"eighty":-0.634332,"marketCap":48632223},{"date":"2024-04-05","current":-1.639046,"twenty":-2.841661,"median":-1.133888,"eighty":-0.637174,"marketCap":49417222},{"date":"2024-04-12","current":-1.733606,"twenty":-2.81438,"median":-1.135062,"eighty":-0.638291,"marketCap":52268216},{"date":"2024-04-19","current":-0.951907,"twenty":-2.769638,"median":-1.136051,"eighty":-0.644105,"marketCap":28700002},{"date":"2024-04-26","current":-1.085347,"twenty":-2.749995,"median":-1.134505,"eighty":-0.649221,"marketCap":32723199},{"date":"2024-05-03","current":-0.712043,"twenty":-2.736899,"median":-1.134356,"eighty":-0.65146,"marketCap":21468086},{"date":"2024-05-10","current":-1.01276,"twenty":-2.728169,"median":-1.131453,"eighty":-0.653503,"marketCap":30534704},{"date":"2024-05-17","current":-1.430763,"twenty":-2.721622,"median":-1.130571,"eighty":-0.654502,"marketCap":36683331},{"date":"2024-05-24","current":-1.47141,"twenty":-2.713983,"median":-1.134208,"eighty":-0.655209,"marketCap":37725471},{"date":"2024-05-31","current":-1.508866,"twenty":-2.7118,"median":-1.135062,"eighty":-0.656118,"marketCap":38685819},{"date":"2024-06-07","current":-1.394061,"twenty":-2.709618,"median":-1.138768,"eighty":-0.657233,"marketCap":35742333},{"date":"2024-06-14","current":-1.438979,"twenty":-2.69434,"median":-1.144796,"eighty":-0.657793,"marketCap":36893975},{"date":"2024-06-21","current":-1.213093,"twenty":-2.646324,"median":-1.152735,"eighty":-0.657925,"marketCap":31102479},{"date":"2024-06-28","current":-1.095966,"twenty":-2.631046,"median":-1.152735,"eighty":-0.657941,"marketCap":28099481},{"date":"2024-07-05","current":-1.079234,"twenty":-2.604856,"median":-1.144796,"eighty":-0.658424,"marketCap":27670481},{"date":"2024-07-12","current":-1.012305,"twenty":-2.588487,"median":-1.136551,"eighty":-0.660329,"marketCap":25954483},{"date":"2024-07-15","current":-1.037403,"twenty":-2.585213,"median":-1.136051,"eighty":-0.660396,"marketCap":26597982},{"date":"2024-08-02","current":-0.899362,"twenty":-2.58194,"median":-1.135552,"eighty":-0.660464,"marketCap":23058734},{"date":"2024-08-09","current":-0.865897,"twenty":-2.572118,"median":-1.134356,"eighty":-0.662745,"marketCap":22200735},{"date":"2024-08-16","current":-0.759129,"twenty":-2.55684,"median":-1.131453,"eighty":-0.667468,"marketCap":18840817},{"date":"2024-08-23","current":-0.890011,"twenty":-2.508824,"median":-1.125933,"eighty":-0.670072,"marketCap":22089175},{"date":"2024-08-30","current":-0.787688,"twenty":-2.466265,"median":-1.118612,"eighty":-0.670817,"marketCap":19549619},{"date":"2024-09-06","current":-0.71021,"twenty":-2.455352,"median":-1.118552,"eighty":-0.671213,"marketCap":17626705},{"date":"2024-09-13","current":-0.774775,"twenty":-2.455352,"median":-1.118159,"eighty":-0.672585,"marketCap":19229133},{"date":"2024-09-20","current":-0.705906,"twenty":-2.431344,"median":-1.117098,"eighty":-0.674861,"marketCap":17519877},{"date":"2024-09-27","current":-0.731732,"twenty":-2.388785,"median":-1.109611,"eighty":-0.675881,"marketCap":18160848},{"date":"2024-10-04","current":-0.658558,"twenty":-2.300392,"median":-1.103275,"eighty":-0.675881,"marketCap":16344763},{"date":"2024-10-11","current":-0.591842,"twenty":-2.125585,"median":-1.10041,"eighty":-0.670659,"marketCap":14688921},{"date":"2024-10-18","current":-0.544494,"twenty":-2.032742,"median":-1.09973,"eighty":-0.661505,"marketCap":13513807},{"date":"2024-10-25","current":-0.520821,"twenty":-2.014195,"median":-1.09846,"eighty":-0.657941,"marketCap":12926250},{"date":"2024-10-31","current":-0.615515,"twenty":-2.000594,"median":-1.095168,"eighty":-0.655863,"marketCap":15276478},{"date":"2024-11-08","current":-0.559559,"twenty":-1.986509,"median":-1.087986,"eighty":-0.650669,"marketCap":13887707},{"date":"2024-11-15","current":-0.499299,"twenty":-1.966512,"median":-1.086526,"eighty":-0.637782,"marketCap":12392108},{"date":"2024-11-22","current":-0.644745,"twenty":-1.952372,"median":-1.085324,"eighty":-0.637135,"marketCap":13139907},{"date":"2024-11-29","current":-0.77525,"twenty":-1.947426,"median":-1.082388,"eighty":-0.637527,"marketCap":15799596},{"date":"2024-12-06","current":-0.704235,"twenty":-1.916515,"median":-1.079965,"eighty":-0.638801,"marketCap":14352305},{"date":"2024-12-13","current":-0.710153,"twenty":-1.904262,"median":-1.079234,"eighty":-0.642124,"marketCap":14472913},{"date":"2024-12-20","current":-0.899527,"twenty":-1.879421,"median":-1.069184,"eighty":-0.644745,"marketCap":18332356},{"date":"2024-12-27","current":-0.905445,"twenty":-1.879421,"median":-1.064958,"eighty":-0.645466,"marketCap":18452964},{"date":"2025-01-03","current":-1.769464,"twenty":-1.868293,"median":-1.064958,"eighty":-0.646843,"marketCap":36061675},{"date":"2025-01-10","current":-2.225145,"twenty":-1.894326,"median":-1.069184,"eighty":-0.648694,"marketCap":45348461},{"date":"2025-01-17","current":-2.521042,"twenty":-1.963286,"median":-1.079234,"eighty":-0.651064,"marketCap":51378841},{"date":"2025-01-24","current":-1.733956,"twenty":-2.000594,"median":-1.079234,"eighty":-0.652668,"marketCap":35338029},{"date":"2025-01-31","current":-1.769464,"twenty":-2.000594,"median":-1.08184,"eighty":-0.654393,"marketCap":36061675},{"date":"2025-02-07","current":-1.881905,"twenty":-1.986509,"median":-1.085324,"eighty":-0.65481,"marketCap":38353219},{"date":"2025-02-14","current":-1.739874,"twenty":-1.966512,"median":-1.086526,"eighty":-0.655863,"marketCap":35458637},{"date":"2025-02-21","current":-1.449895,"twenty":-1.953609,"median":-1.087663,"eighty":-0.656882,"marketCap":29548864},{"date":"2025-02-28","current":-1.355208,"twenty":-1.947426,"median":-1.09437,"eighty":-0.65776,"marketCap":27619142},{"date":"2025-03-07","current":-1.278275,"twenty":-1.916515,"median":-1.09846,"eighty":-0.657925,"marketCap":26051243},{"date":"2025-03-14","current":-1.714739,"twenty":-1.905577,"median":-1.09973,"eighty":-0.657965,"marketCap":34946389},{"date":"2025-03-21","current":-1.393592,"twenty":-1.904262,"median":-1.10041,"eighty":-0.658558,"marketCap":35015389},{"date":"2025-03-28","current":-1.393592,"twenty":-1.881905,"median":-1.103275,"eighty":-0.660261,"marketCap":35015389},{"date":"2025-04-04","current":-1.258945,"twenty":-1.879421,"median":-1.109611,"eighty":-0.660471,"marketCap":31632259},{"date":"2025-04-11","current":-1.205087,"twenty":-1.879421,"median":-1.117098,"eighty":-0.660599,"marketCap":30279008},{"date":"2025-04-17","current":-1.299339,"twenty":-1.864583,"median":-1.118159,"eighty":-0.66241,"marketCap":32647198},{"date":"2025-04-25","current":-1.393592,"twenty":-1.858761,"median":-1.118355,"eighty":-0.663913,"marketCap":35015389},{"date":"2025-05-02","current":-1.400324,"twenty":-1.850454,"median":-1.118612,"eighty":-0.665406,"marketCap":35184545}],"updateTime":1746385115546}}}